Inhibitors | Comment | Organism | Structure |
---|---|---|---|
enalaprilate | - |
Sus scrofa | |
lisinopril | - |
Sus scrofa |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
170000 | - |
x * 170000, one enzyme form from striatum, SDS-PAGE | Sus scrofa |
180000 | - |
x * 180000, one enzyme form from striatum and kindey enzyme | Sus scrofa |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Sus scrofa | - |
- |
- |
Posttranslational Modification | Comment | Organism |
---|---|---|
side-chain modification | the 180000 Da enzyme form contains approximately 17% carbohydrate | Sus scrofa |
Purification (Comment) | Organism |
---|---|
- |
Sus scrofa |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
brain | striatum, 2 enzyme forms: MW 170000 Da and MW 180000 Da | Sus scrofa | - |
kidney | one enzyme form of 180000 Da | Sus scrofa | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
1.766 | - |
- |
Sus scrofa |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
angiotensin I + H2O | - |
Sus scrofa | angiotensin II + His-Leu | - |
? | |
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 + H2O | primary cleavage of Phe8-Gly9 | Sus scrofa | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly + Leu-Met-NH2 | - |
? | |
benzoyl-Gly-His-Leu + H2O | - |
Sus scrofa | benzoyl-Gly + His-Leu | - |
? | |
bradykinin + H2O | - |
Sus scrofa | Phe-Arg + Ser-Pro + Arg-Pro-Pro-Gly-Phe | - |
? | |
[D-Ala2,Leu5]enkephalin + H2O | - |
Sus scrofa | Tyr-D-Ala-Gly + Phe-Leu | - |
? |
Subunits | Comment | Organism |
---|---|---|
? | x * 180000, one enzyme form from striatum and kindey enzyme | Sus scrofa |
? | x * 170000, one enzyme form from striatum, SDS-PAGE | Sus scrofa |